Research Funded by Box Rallies

Featured Research

Professor Clark and her team are exploring and exploiting the Epigenetic Basis of Endocrine Resistant Breast Cancer.

Explore Research

Improving the health and well-being of women cancer survivors

Investigating a gene that helps neuroblastomas grow blood vessels and spread throughout the body

Investigating why a new brain cancer drug works in some patients but not others

Leveraging stem-like memory T cells for effective anti-cancer mRNA vaccines

Linking gut bacteria to the development of early onset colorectal cancer using multi-omic profiling

MARCH5 is a master regulator of BCL2 proteins and a potential anti-cancer drug target

Melanoma Genome Mapping

Melanoma Margins Trial: A Phase III, Multi-centre Randomised Controlled Trial

Monitoring a patient’s real-time response to a new immunotherapy

Nanobody-mediated modulation of unconventional T cells for cancer immunotherapy

Novel Treatment Targets in Low-Grade Serous Ovarian Cancer

Pan-cancer assessment of sensitivity towards novel selective oncogenic JNK inhibitors

Precision targeting of regulatory T cells for solid cancer immunotherapy

Predicting clinical response to breast cancer therapy – the immune signature approach

Preventing people with immune deficiencies from developing cancer

Preventing the outgrowth of cancers that spread to bone

Priming with Belinostat to chemo-sensitise high-risk neuroblastoma

Protein Biosignatures for Predicting Recurrence of Stage II Colorectal Cancer